{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T08:34:01Z","timestamp":1768293241124,"version":"3.49.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1038\/ncpneuro0300","type":"journal-article","created":{"date-parts":[[2006,9,22]],"date-time":"2006-09-22T04:25:35Z","timestamp":1158899135000},"page":"548-556","source":"Crossref","is-referenced-by-count":69,"title":["Narcolepsy and the hypocretin system\u2014where motion meets emotion"],"prefix":"10.1038","volume":"2","author":[{"given":"Jerome M","family":"Siegel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa N","family":"Boehmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpneuro0300_CR1","unstructured":"American Academy of Sleep Medicine Nosology Committee (2005) International Classification of Sleep Disorders. Chicago: American Academy of Sleep Medicine"},{"key":"BFncpneuro0300_CR2","first-page":"631","volume":"7","author":"C Westphal","year":"1877","unstructured":"Westphal C (1877) Eigenth\u00fcmliche mit Einschl\u00e4fen verbundene Anf\u00e4lle. Arch Psychiat 7: 631\u2013635","journal-title":"Arch Psychiat"},{"key":"BFncpneuro0300_CR3","first-page":"626","volume":"64","author":"JBE Gelineau","year":"1881","unstructured":"Gelineau JBE (1881) De la narcolepsie. Surg\u00e8res, Charente-Inferieure: Imprimerie de Surg\u00e8res 64: 626\u2013628","journal-title":"Surg\u00e8res, Charente-Inferieure: Imprimerie de Surg\u00e8res"},{"key":"BFncpneuro0300_CR4","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/79690","volume":"6","author":"C Peyron","year":"2000","unstructured":"Peyron C et al. (2000) A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6: 991\u2013997","journal-title":"Nat Med"},{"key":"BFncpneuro0300_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","volume":"27","author":"TC Thannickal","year":"2000","unstructured":"Thannickal TC et al. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469\u2013474","journal-title":"Neuron"},{"key":"BFncpneuro0300_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L De Lecea","year":"1998","unstructured":"De Lecea L et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95: 322\u2013327","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0300_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92: 573\u2013585","journal-title":"Cell"},{"key":"BFncpneuro0300_CR8","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","volume":"18","author":"C Peyron","year":"1998","unstructured":"Peyron C et al. (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18: 9996\u201310015","journal-title":"J Neurosci"},{"key":"BFncpneuro0300_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1146\/annurev.psych.55.090902.141545","volume":"55","author":"JM Siegel","year":"2004","unstructured":"Siegel JM (2004) Hypocretin (orexin): role in normal behavior and neuropathology. Annu Rev Psychol 55: 125\u2013148","journal-title":"Annu Rev Psychol"},{"key":"BFncpneuro0300_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/cne.10860","volume":"465","author":"DL Rosin","year":"2003","unstructured":"Rosin DL et al. (2003) Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J Comp Neurol 465: 593\u2013603","journal-title":"J Comp Neurol"},{"key":"BFncpneuro0300_CR11","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1523\/JNEUROSCI.18-19-07962.1998","volume":"18","author":"AN van den Pol","year":"1998","unstructured":"van den Pol AN et al. (1998) Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin\/orexin. J Neurosci 18: 7962\u20137971","journal-title":"J Neurosci"},{"key":"BFncpneuro0300_CR12","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1152\/jn.00968.2002","volume":"89","author":"JH Peever","year":"2003","unstructured":"Peever JH et al. (2003) Excitatory effects of hypocretin-1 (orexin-A) in the trigeminal motor nucleus are reversed by NMDA antagonism. J Neurophysiol 89: 2591\u20132600","journal-title":"J Neurophysiol"},{"key":"BFncpneuro0300_CR13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1113\/jphysiol.2002.038729","volume":"548.2","author":"J John","year":"2003","unstructured":"John J et al. (2003) Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J Physiol (Lond) 548.2: 557\u2013562","journal-title":"J Physiol (Lond)"},{"key":"BFncpneuro0300_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0896-6273(02)01132-7","volume":"36","author":"Y Li","year":"2002","unstructured":"Li Y et al. (2002) Hypocretin\/orexin excites hypocretin neurons via a local glutamate neuron\u2014a potential mechanism for orchestrating the hypothalamic arousal system. Neuron 36: 1169\u20131181","journal-title":"Neuron"},{"key":"BFncpneuro0300_CR15","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1523\/JNEUROSCI.0666-05.2005","volume":"25","author":"J Grivel","year":"2005","unstructured":"Grivel J et al. (2005) The wake-promoting hypocretin\/orexin neurons change their response to noradrenaline after sleep deprivation. J Neurosci 25: 4127\u20134130","journal-title":"J Neurosci"},{"key":"BFncpneuro0300_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","volume":"355","author":"S Nishino","year":"2000","unstructured":"Nishino S et al. (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39\u201341","journal-title":"Lancet"},{"key":"BFncpneuro0300_CR17","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","volume":"57","author":"B Ripley","year":"2001","unstructured":"Ripley B et al. (2001) CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions. Neurology 57: 2253\u20132258","journal-title":"Neurology"},{"key":"BFncpneuro0300_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","volume":"184","author":"D Gerashchenko","year":"2003","unstructured":"Gerashchenko D et al. (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184: 1010\u20131016","journal-title":"Exp Neurol"},{"key":"BFncpneuro0300_CR19","doi-asserted-by":"publisher","first-page":"R1079","DOI":"10.1152\/ajpregu.00207.2002","volume":"283","author":"MF Wu","year":"2002","unstructured":"Wu MF et al. (2002) Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol 283: R1079\u2013R1086","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFncpneuro0300_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1750-3639.2003.tb00033.x","volume":"13","author":"TC Thannickal","year":"2003","unstructured":"Thannickal TC et al. (2003) Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 13: 340\u2013351","journal-title":"Brain Pathol"},{"key":"BFncpneuro0300_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","volume":"65","author":"AM Blouin","year":"2005","unstructured":"Blouin AM et al. (2005) Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology 65: 1189\u20131192","journal-title":"Neurology"},{"key":"BFncpneuro0300_CR22","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","volume":"65","author":"A Crocker","year":"2005","unstructured":"Crocker A et al. (2005) Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65: 1184\u20131188","journal-title":"Neurology"},{"key":"BFncpneuro0300_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-3-642-83387-8_7","volume-title":"HLA in Narcolepsy","author":"J Montplaisir","year":"1988","unstructured":"Montplaisir J and Poirier G (1988) HLA in narcolepsy in Canada. In HLA in Narcolepsy, 97\u2013107 (Eds Honda Y and Juji T) Berlin: Springer-Verlag"},{"key":"BFncpneuro0300_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.sleep.2005.04.002","volume":"6","author":"N Tachibana","year":"2005","unstructured":"Tachibana N et al. (2005) Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma. Sleep Med 6: 567\u2013569","journal-title":"Sleep Med"},{"key":"BFncpneuro0300_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","volume":"9","author":"S Nishino","year":"2005","unstructured":"Nishino S and Kanbayashi T (2005) Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system. Sleep Med Rev 9: 269\u2013310","journal-title":"Sleep Med Rev"},{"issue":"8 Suppl","key":"BFncpneuro0300_CR26","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1093\/sleep\/17.suppl_8.S13","volume":"17","author":"M Partinen","year":"1994","unstructured":"Partinen M et al. (1994) Twin studies in narcolepsy. Sleep 17 (8 Suppl): S13\u2013S16","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR27","first-page":"360","volume":"38","author":"Y Honda","year":"1984","unstructured":"Honda Y et al. (1984) Narcolepsy and HLA: positive DR2 as a prerequisite for the development of narcolepsy. Folia Psychiatr Neurol Jpn 38: 360","journal-title":"Folia Psychiatr Neurol Jpn"},{"key":"BFncpneuro0300_CR28","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1086\/318799","volume":"68","author":"E Mignot","year":"2001","unstructured":"Mignot E et al. (2001) Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68: 686\u2013699","journal-title":"Am J Hum Genet"},{"key":"BFncpneuro0300_CR29","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1972595","volume":"248","author":"AA Sinha","year":"1990","unstructured":"Sinha AA et al. (1990) Autoimmune diseases: the failure of self tolerance. Science 248: 1380\u20131388","journal-title":"Science"},{"key":"BFncpneuro0300_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jneuroim.2006.02.010","volume":"174","author":"S Overeem","year":"2006","unstructured":"Overeem S et al. (2006) Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol 174: 187\u2013191","journal-title":"J Neuroimmunol"},{"key":"BFncpneuro0300_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-3940(03)00085-5","volume":"341","author":"S Overeem","year":"2003","unstructured":"Overeem S et al. (2003) Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neurosci Lett 341: 13\u201316","journal-title":"Neurosci Lett"},{"key":"BFncpneuro0300_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/sleep\/25.7.719","volume":"25","author":"JL Black III","year":"2002","unstructured":"Black JL III et al. (2002) Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Sleep 25: 719\u2013723","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0896-6273(04)00247-8","volume":"42","author":"J John","year":"2004","unstructured":"John J et al. (2004) Cataplexy-active neurons in the posterior hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron 42: 619\u2013634","journal-title":"Neuron"},{"key":"BFncpneuro0300_CR34","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1126\/science.1925546","volume":"252","author":"JM Siegel","year":"1991","unstructured":"Siegel JM et al. (1991) Neuronal activity in narcolepsy: identification of cataplexy related cells in the medial medulla. Science 252: 1315\u20131318","journal-title":"Science"},{"key":"BFncpneuro0300_CR35","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0306-4522(98)00600-9","volume":"91","author":"MF Wu","year":"1999","unstructured":"Wu MF et al. (1999) Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience 91: 1389\u20131399","journal-title":"Neuroscience"},{"key":"BFncpneuro0300_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neuron.2005.04.035","volume":"46","author":"BY Mileykovskiy","year":"2005","unstructured":"Mileykovskiy BY et al. (2005) Behavioral correlates of activity in identified hypocretin\/orexin neurons. Neuron 46: 787\u2013798","journal-title":"Neuron"},{"key":"BFncpneuro0300_CR37","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1523\/JNEUROSCI.5560-03.2004","volume":"24","author":"CT Beuckmann","year":"2004","unstructured":"Beuckmann CT et al. (2004) Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24: 4469\u20134477","journal-title":"J Neurosci"},{"key":"BFncpneuro0300_CR38","first-page":"125","volume-title":"Narcolepsy","author":"C Guilleminault","year":"1976","unstructured":"Guilleminault C (1976) Cataplexy. In Narcolepsy, 125\u2013143 (Eds Guilleminault C et al.) New York: Spectrum"},{"key":"BFncpneuro0300_CR39","doi-asserted-by":"publisher","first-page":"6716","DOI":"10.1523\/JNEUROSCI.1887-05.2005","volume":"25","author":"MG Lee","year":"2005","unstructured":"Lee MG et al. (2005) Discharge of identified orexin\/hypocretin neurons across the sleep-waking cycle. J Neurosci 25: 6716\u20136720","journal-title":"J Neurosci"},{"key":"BFncpneuro0300_CR40","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/sleep\/26.7.809","volume":"26","author":"M Hecht","year":"2003","unstructured":"Hecht M et al. (2003) Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep 26: 809\u2013810","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/ana.20339","volume":"56","author":"Y Dauvilliers","year":"2004","unstructured":"Dauvilliers Y et al. (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56: 905\u2013908","journal-title":"Ann Neurol"},{"key":"BFncpneuro0300_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","volume":"12","author":"M Lecendreux","year":"2003","unstructured":"Lecendreux M et al. (2003) Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 12: 347\u2013348","journal-title":"J Sleep Res"},{"key":"BFncpneuro0300_CR43","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.expneurol.2004.04.006","volume":"188","author":"LN Boehmer","year":"2004","unstructured":"Boehmer LN et al. (2004) Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Exp Neurol 188: 292\u2013299","journal-title":"Exp Neurol"},{"key":"BFncpneuro0300_CR44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(24)38126-1","volume":"289","author":"AJ Kastin","year":"1999","unstructured":"Kastin AJ and Akerstrom V (1999) Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. J Pharmacol Exp Ther 289: 219\u2013223","journal-title":"J Pharmacol Exp Ther"},{"key":"BFncpneuro0300_CR45","first-page":"A12","volume":"23","author":"J John","year":"2000","unstructured":"John J et al. (2000) Hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep 23: A12","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR46","first-page":"932","volume":"26","author":"JM Siegel","year":"2003","unstructured":"Siegel JM (2003) Hypocretin administration as a treatment for human narcolepsy. Sleep 26: 932\u2013933","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","volume":"26","author":"N Fujiki","year":"2003","unstructured":"Fujiki N et al. (2003) Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog. Sleep 26: 953\u2013959","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR48","doi-asserted-by":"publisher","first-page":"5164","DOI":"10.1210\/en.2005-0455","volume":"146","author":"ML Barreiro","year":"2005","unstructured":"Barreiro ML et al. (2005) Pattern of orexin expression and direct biological actions of orexin-A in rat testis. Endocrinology 146: 5164\u20135175","journal-title":"Endocrinology"},{"key":"BFncpneuro0300_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.regpep.2004.07.010","volume":"124","author":"S Zhang","year":"2005","unstructured":"Zhang S et al. (2005) Expression of orexin receptors in the brain and peripheral tissues of the male sheep. Regul Pept 124: 81\u201387","journal-title":"Regul Pept"},{"key":"BFncpneuro0300_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.regpep.2005.07.005","volume":"132","author":"M Ehrstrom","year":"2005","unstructured":"Ehrstrom M et al. (2005) Stimulatory effect of endogenous orexin A on gastric emptying and acid secretion independent of gastrin. Regul Pept 132: 9\u201316","journal-title":"Regul Pept"},{"key":"BFncpneuro0300_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/edrv.23.1.0454","volume":"23","author":"AL Kirchgessner","year":"2002","unstructured":"Kirchgessner AL (2002) Orexins in the brain\u2013gut axis. Endocr Rev 23: 1\u201315","journal-title":"Endocr Rev"},{"key":"BFncpneuro0300_CR52","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1073\/pnas.0400590101","volume":"101","author":"M Mieda","year":"2004","unstructured":"Mieda M et al. (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA 101: 4649\u20134654","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpneuro0300_CR53","first-page":"66","volume":"4","author":"LR Hanson","year":"2004","unstructured":"Hanson LR et al. (2004) Intranasal administration of hypocretin 1 (orexin A) bypasses the blood\u2013brain barrier and targets the brain: a new strategy for the treatment of narcolepsy. Drug Delivery Technology 4: 66\u201371","journal-title":"Drug Delivery Technology"},{"key":"BFncpneuro0300_CR54","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nn0602-849","volume":"5","author":"J Born","year":"2002","unstructured":"Born J et al. (2002) Sniffing neuropeptides: a transnasal approach to the human brain. Nat Neurosci 5: 514\u2013516","journal-title":"Nat Neurosci"},{"key":"BFncpneuro0300_CR55","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroscience.2005.02.003","volume":"132","author":"JP Wisor","year":"2005","unstructured":"Wisor JP and Eriksson KS (2005) Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132: 1027\u20131034","journal-title":"Neuroscience"},{"key":"BFncpneuro0300_CR56","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.neuroscience.2004.10.005","volume":"130","author":"JT Willie","year":"2005","unstructured":"Willie JT et al. (2005) Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience 130: 983\u2013995","journal-title":"Neuroscience"},{"key":"BFncpneuro0300_CR57","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/sleep\/28.6.754","volume":"28","author":"E Mignot","year":"2005","unstructured":"Mignot E and Nishino S (2005) Emerging therapies in narcolepsy\u2013cataplexy. Sleep 28: 754\u2013763","journal-title":"Sleep"},{"key":"BFncpneuro0300_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejphar.2006.03.039","volume":"538","author":"LP Carter","year":"2006","unstructured":"Carter LP et al. (2006) Discriminative stimulus effects of GHB and GABAB agonists are differentially attenuated by CGP35348. Eur J Pharmacol 538: 85\u201393","journal-title":"Eur J Pharmacol"}],"container-title":["Nature Clinical Practice Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0300","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/ncpneuro0300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneuro0300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T23:22:13Z","timestamp":1736551333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneuro0300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["BFncpneuro0300"],"URL":"https:\/\/doi.org\/10.1038\/ncpneuro0300","relation":{},"ISSN":["1745-834X","1745-8358"],"issn-type":[{"value":"1745-834X","type":"print"},{"value":"1745-8358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}